DM
PCRX icon

Deerfield Management’s Pacira BioSciences PCRX Stock Holding History

Deerfield Management’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-17,062
Closed -$488K – 600
2024
Q2 		$488K Buy
+17,062
New +$486K 0.01% 265
2023
Q1 		– Sell
-292,000
Closed -$11.3M – 110
2022
Q4 		$11.3M Hold
292,000
– – 0.23% 70
2022
Q3 		$15.5M Hold
292,000
– – 0.31% 72
2022
Q2 		$17M Buy
+292,000
New +$19.1M 0.35% 66
2022
Q1 		– Sell
-596,338
Closed -$35.9M – 127
2021
Q4 		$35.9M Sell
596,338
-370,898
-38% -$20.5M 0.75% 40
2021
Q3 		$54.2M Sell
967,236
-179,764
-16% -$10.4M 1.06% 28
2021
Q2 		$69.6M Sell
1,147,000
-17,973
-2% -$1.14M 1.24% 20
2021
Q1 		$81.7M Buy
1,164,973
+115,326
+11% +$8.24M 1.72% 14
2020
Q4 		$62.8M Sell
1,049,647
-148,178
-12% -$8.68M 1.24% 20
2020
Q3 		$72M Sell
1,197,825
-465,175
-28% -$27M 1.75% 15
2020
Q2 		$87.3M Buy
1,663,000
+35,479
+2% +$1.48M 2.54% 9
2020
Q1 		$54.6M Buy
+1,627,521
New +$67.6M 1.73% 16
2016
Q3 		– Sell
-50,000
Closed -$1.69M – 101
2016
Q2 		$1.69M Buy
+50,000
New +$2.46M 0.07% 90
2016
Q1 		– Sell
-371,000
Closed -$28.5M – 112
2015
Q4 		$28.5M Sell
371,000
-331,485
-47% -$18.8M 1.15% 35
2015
Q3 		$28.9M Buy
702,485
+490,485
+231% +$30M 1.12% 33
2015
Q2 		$15M Buy
+212,000
New +$16.7M 0.5% 62

Other funds holding PCRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $372M AUM 14.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Deerfield Management's PCRX Position: Q3 2024 in Review

Deerfield Management sold out of Pacira BioSciences (PCRX) in Q3 2024, closing a stake of 17,062 shares — an estimated $488K sold.

Deerfield Management first reported a position in PCRX in Q2 2015 and held it in 16 quarters. The position peaked at $87.3M in Q2 2020. 239 funds tracked by Wall St. Rank hold PCRX as of Q3 2024.

  • Deerfield Management reported no remaining Pacira BioSciences position as of Q3 2024 after selling out during the quarter.
  • Deerfield Management sold 17,062 Pacira BioSciences shares in Q3 2024, an estimated $488K.
  • Deerfield Management first reported a position in Pacira BioSciences in Q2 2015 and held it in 16 quarters.
  • Deerfield Management's Pacira BioSciences position peaked at $87.3M in Q2 2020.
  • 239 funds tracked by Wall St. Rank held Pacira BioSciences as of Q3 2024.

Based on Deerfield Management's 13F filing for Q3 2024, filed 14 Nov 2024.